Live Breaking News & Updates on Michaelj Mcbreen

Stay updated with breaking news from Michaelj mcbreen. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Integra LifeSciences (NASDAQ:IART) Issues FY 2023 Earnings Guidance

Thomson Reuters consensus EPS estimate of $3.47. The company issued revenue guidance of $2.1 billion-$2.2 billion, compared to the consensus revenue estimate of $2.15 billion.

The company updated its FY2023 earnings and revenue guidance. ....

Michaelj Mcbreen , Integra Lifescience , Integra Lifesciences , Morgan Stanley , Covestor Ltd , Topco Ltd , Neuberger Berman Group , Integra Lifesciences Holdings Corp , Institutional Capital , Financial Advisors , Berman Group , Lifesciences Holdings , Codman Specialty Surgical , Tissue Technologies ,

Integra LifeSciences (NASDAQ:IART) Price Target Lowered to $44.00 at Truist Financial

Integra LifeSciences (NASDAQ:IART – Get Rating) had its price objective cut by Truist Financial from $54.00 to $44.00 in a report published on Tuesday morning, The Fly reports. A number of other equities analysts have also recently weighed in on IART. TheStreet cut Integra LifeSciences from a b- rating to a c+ rating in a […] ....

Integra Lifesciences , Michaelj Mcbreen , Century Group , Proficio Capital Partners , Jpmorgan Chase Co , Ronald Blue Trust Inc , Global Retirement Partners , Third Bancorp , Integra Lifesciences Holdings Corp , Fifth Third Bancorp , Get Rating , Truist Financial , Blue Trust , Ivy Capital Management , Capital Partners , Retirement Partners , Lifesciences Holdings , Codman Specialty Surgical , Tissue Technologies , Integra Lifesciences Daily , Nasdaq Iart , Lower Price Target , Truist Financial Co ,

Integra LifeSciences (NASDAQ:IART) Downgraded by Citigroup

Citigroup downgraded shares of Integra LifeSciences (NASDAQ:IART – Get Rating) from a neutral rating to a sell rating in a research note issued to investors on Tuesday, The Fly reports. Citigroup currently has $39.00 price objective on the life sciences company’s stock, down from their previous price objective of $59.00. Several other brokerages also recently […] ....

Integra Lifesciences , Michaelj Mcbreen , Lisa Evoli , Metlife Investment Management , Yousif Capital Management , Raymond James Associates , Commonwealth Of Pennsylvania Public School Empls Retrmt , Great West Life Assurance Co , Securities Exchange Commission , Integra Lifesciences Holdings Corp , Get Rating , Truist Financial , Exchange Commission , Life Investment Management , Pennsylvania Public School Empls Retrmt , West Life Assurance , Capital Management , Lifesciences Holdings , Codman Specialty Surgical , Tissue Technologies , Integra Lifesciences Daily , Nasdaq Iart , Citigroup Inc ,

Integra LifeSciences' (IART) Downgrade Rating Reaffirmed at 22nd Century Group

22nd Century Group reaffirmed their downgrade rating on shares of Integra LifeSciences (NASDAQ:IART – Get Rating) in a report published on Tuesday morning, Benzinga reports. Several other equities research analysts have also recently commented on IART. Citigroup cut Integra LifeSciences from a neutral rating to a sell rating and lowered their price target for the […] ....

Integra Lifesciences , Lisa Evoli , Michaelj Mcbreen , Jpmorgan Chase Co , Proficio Capital Partners , Third Bancorp , Global Retirement Partners , Integra Lifesciences Company Profile , Fifth Third Bancorp , Securities Exchange Commission , Century Group , Integra Lifesciences Holdings Corp , Ronald Blue Trust Inc , Get Rating , Truist Financial , Lifesciences Trading Down , Exchange Commission , Blue Trust , Ivy Capital Management , Capital Partners , Retirement Partners , Lifesciences Holdings , Codman Specialty Surgical , Tissue Technologies , Integra Lifesciences Daily , Nasdaq Iart ,